Publication | Open Access
cfDNA and DNases: New Biomarkers of Sepsis in Preterm Neonates—A Pilot Study
27
Citations
16
References
2022
Year
A total of 31 preterm neonates with suspected sepsis were included. Out of these, nine patients met the criteria for sepsis according to EMA. Regarding early onset neonatal sepsis (3 EONS vs. 10 controls), cfDNA, DNase I, nucleosome, and CRP were elevated significantly. H3Cit and NE did not show any significant elevations. In the late onset sepsis collective (6 LONS vs. 12 controls), cfDNA, DNase I, and CRP differed significantly compared to control group.
| Year | Citations | |
|---|---|---|
Page 1
Page 1